Suppr超能文献

制备并表征鼠李糖乳杆菌的凝聚体延长释放微粒给药系统。

Preparation and characterization of a coacervate extended-release microparticulate delivery system for Lactobacillus rhamnosus.

机构信息

Department of Pharmaceutical Technology, Jadavpur University, Kolkata, West Bengal, India.

出版信息

Int J Nanomedicine. 2011;6:1699-707. doi: 10.2147/IJN.S19589. Epub 2011 Aug 19.

Abstract

BACKGROUND

The purpose of this study was to develop a mucoadhesive coacervate microparticulate system to deliver viable Lactobacillus rhamnosus cells into the gut for an extended period of time while maintaining high numbers of viable cells within the formulation throughout its shelf-life and during gastrointestinal transit.

METHODS

Core coacervate mucoadhesive microparticles of L. rhamnosus were developed using several grades of hypromellose and were subsequently enteric-coated with hypromellose phthalate. Microparticles were evaluated for percent yield, entrapment efficiency, surface morphology, particle size, size distribution, zeta potential, flow properties, in vitro swelling, mucoadhesion properties, in vitro release profile and release kinetics, in vivo probiotic activity, and stability. The values for the kinetic constant and release exponent of model-dependent approaches, the difference factor, similarity factor, and Rescigno indices of model-independent approaches were determined for analyzing in vitro dissolution profiles.

RESULTS

Experimental microparticles of formulation batches were of spherical shape with percent yields of 41.24%-58.18%, entrapment efficiency 45.18%-64.16%, mean particle size 33.10-49.62 μm, and zeta potential around -11.5 mV, confirming adequate stability of L. rhamnosus at room temperature. The in vitro L. rhamnosus release profile follows zero-order kinetics and depends on the grade of hypromellose and the L. rhamnosus to hypromellose ratio.

CONCLUSION

Microparticles delivered L. rhamnosus in simulated intestinal conditions for an extended period, following zero-order kinetics, and exhibited appreciable mucoadhesion in simulated intestinal conditions.

摘要

背景

本研究旨在开发一种黏膜黏附共凝聚微粒系统,将活菌鼠李糖乳杆菌递送至肠道,延长其在制剂中的存活时间,并在整个保质期内和胃肠道转运过程中保持高数量的活菌。

方法

使用几种等级的羟丙甲纤维素开发了核心共凝聚黏膜黏附微粒的鼠李糖乳杆菌,随后用羟丙甲纤维素邻苯二甲酸酯对其进行肠溶包衣。对微粒的产率、包封效率、表面形态、粒径、粒径分布、Zeta 电位、流动特性、体外膨胀、黏膜黏附特性、体外释放曲线和释放动力学、体内益生菌活性和稳定性进行了评估。通过模型依赖方法的动力学常数和释放指数、差异因子、相似因子和非模型依赖方法的 Rescigno 指数来确定分析体外溶解曲线的模型。

结果

制剂批的实验性微粒呈球形,产率为 41.24%-58.18%,包封效率为 45.18%-64.16%,平均粒径为 33.10-49.62μm,Zeta 电位在-11.5mV 左右,证实了室温下鼠李糖乳杆菌的稳定性良好。体外鼠李糖乳杆菌释放曲线遵循零级动力学,取决于羟丙甲纤维素的等级和鼠李糖乳杆菌与羟丙甲纤维素的比例。

结论

微粒在模拟肠道条件下以零级动力学延长了鼠李糖乳杆菌的释放时间,并在模拟肠道条件下表现出明显的黏膜黏附性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d26e/3184930/04d81fd21426/ijn-6-1699f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验